Dyrbye Liselotte N, Redfield Margaret M
Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Heart Fail Rev. 2003 Oct;8(4):349-54. doi: 10.1023/a:1026143231117.
While measurement of plasma BNP concentration has been shown to be useful in the diagnosis of heart failure, its role as a screening test for detection of pre-clinical ventricular remodeling or dysfunction in the general population has not been established. Here we review available population-based studies assessing the predictive characteristics of BNP for the detection of pre-clinical structural heart disease (Stage B Heart Failure).